Auna Q3 2026 slides: revenue surges 10% as cash flow doubles

Auna S.A. reported Q3 2026 revenue of S/1,325 million, up 10% FXN, with free cash flow doubling YoY. Adjusted EBITDA was flat YoY at S/231 million, with margins compressing. Stock traded at $4.84 premarket, up 1.47%. Challenges included currency depreciation and regulatory headwinds in key markets.

Original reporting
Published Nov 18, 2026, 2:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 18, 2026, 2:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AUNA
Neutral
medium confidence
Mentioned
$AUNA
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AUNANeutralMed
01

Why it matters

The key trading tension is upside in revenue growth and free cash flow versus downside in adjusted EBITDA and margin compression, with management also referencing revised profitability guidance.

02

Market read

For traders, this is a fresh earnings datapoint with enough detail to reassess near-term profitability expectations and cash-flow durability.

03

What to watch

Free cash flow surge is driven by working-capital and lower tax payments; traders should watch whether collections normalize and whether hedging changes reduce future FX variance.

Relevance 8/10Novelty 7/10Timing: premarket today after Q3 2026 earnings release

Background

Auna S.A. delivered its Q3 2026 earnings presentation on Nov 18, 2026, showing revenue growth across Mexico, Peru, and Colombia while citing temporary margin pressures in Peru and Colombia.

Company-level read

Ticker impact

$AUNANeutralMedium confidence
Context

Auna S.A. reported Q3 2026 revenues up 10% FX-neutral and said free cash flow nearly doubled, while adjusted EBITDA margin compressed to 17.5%.

Expected impact

Likely choppy trading as investors weigh the cash-flow beat against weaker adjusted EBITDA/margin and guidance risk.

Evidence & confidence

The article provides both upside (revenue growth, free cash flow +95% YoY) and downside (adjusted EBITDA flat, margin down 330 bps) plus explicit mention of revised profitability guidance.

Market effects

Highlights margin volatility in Latin American healthcare delivery and payor mix sensitivity, which can affect read-across for regional healthcare operators.

Emphasizes FX headwinds (Mexico, Colombia) and local regulatory/payor dynamics that can influence sentiment toward LatAm healthcare equities.

Limited direct global spillover, but reinforces investor focus on cash conversion versus EBITDA margins in healthcare services.

Counterpoint

The margin compression may be largely explained by identifiable one-off items (receivables reconciliation penalties, payor contract issues), so the market may over-discount the earnings quality.

Key entities

  • Auna S.A.

    Latin American healthcare platform reporting Q3 2026 results with revenue growth, margin compression, and a large free cash flow increase.

Related articles

$AUNAMed

Auna S.A. (AUNA) Stock Falls on Q3 2026 Earnings

Auna S.A. (AUNA) reported Q3 2026 revenue of $384.7M, up 19.4% YoY, with net income falling 57.4% to $5.9M. Operating cash flow rose 38.9% to $77.6M. Insiders made 6 purchases and 1 sale in the past 6 months. Hedge funds showed mixed activity, with some increasing and others decreasing positions.

$AUNAMed

AUNA S.A. (AUNA): Financial results for Q3 2026

AUNA S.A. (AUNA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Auna Announces 3Q26 Financial Results Auna reports 10% FX-Neutral Revenue Growth and Continued Strong Cash Generation in 3Q2026; Mexico Returns to Year-over-Year Adjusted EBITDA Growth; Profitability Pressured by Specific Headwinds in Colombia and Peru Leverage Impro

$AUNAHigh

Why is Auna stock dropping today?

Auna SAA ADR stock fell 9.2% to $4.91 after revising its 2026 profitability outlook, citing higher cancer diagnosis costs in Colombia. The company maintained its revenue growth target but saw a sell-off amid broader market declines. The stock dropped to a session low of $4.55, nearing its 52-week low of $4.09.

$AUNAMed

Auna (AUNA) Q2 2026 Earnings Call Transcript

Auna (AUNA) reported Q2 2026 results with 9% revenue growth driven by volume and higher complexity services. Adjusted EBITDA declined 9% due to margin pressures in Mexico and Colombia, and billing penalties in Peru. Mexico saw 7% surgery and 20% oncology volume growth, while Peru achieved 8% revenue growth. Colombia's adjusted EBITDA increased 18% sequentially. Leverage decreased to 3.6x, and cash increased 43% year-over-year.

$AUNAMed

Auna Q2 Earnings Call Highlights

Auna reported Q2 revenue growth in Mexico (4% YoY), Peru (8%), and Colombia (13%), but adjusted EBITDA varied. Mexico's EBITDA declined 16% YoY due to investments, while Peru's was flat due to billing penalties. Colombia's EBITDA fell 12% YoY but rose 18% sequentially. The company reaffirmed its full-year guidance, expecting 12% FX-neutral revenue growth and adjusted EBITDA growth toward the low end of its 10-14% target range, excluding Peru's billing penalties. Cash flow and leverage improved,